Vildagliptin
ویلداگلیپتین
🍽️ Alimentary Tract And MetabolismDPP-4 inhibitor
Market / country: UK
Galvus (UK)
🧮 Dose calculator
Type 2 diabetes mellitus · Regimen source: UK Galvus SmPC · 4.2
- • Doses above 100 mg/day not recommended. In dual combination with a sulphonylurea, 50 mg once in the morning. UK Galvus SmPC · 4.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to vildagliptin. UK Galvus SmPC · 4.3
Warnings
- • Not for hepatic impairment or ALT/AST >3× ULN; monitor liver enzymes. UK Galvus SmPC · 4.4
Formulations
- 50 mg tablet — tablet UK UK Galvus SmPC · 4.2
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. UK Galvus SmPC · 4.6
“There are no adequate data from the use of vildagliptin in pregnant women.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. UK Galvus SmPC · 4.6
“Animal studies have shown excretion of vildagliptin in milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. UK Galvus SmPC · 4.2
“The safety and efficacy of Galvus in children and adolescents (< 18 years) have not been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. UK Galvus SmPC · 4.2
“Elderly (≥ 65 years) No dose adjustments are necessary in elderly patients (see also sections 5.1 and 5.2).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)❌ None
- DailyMed (FDA label)❌ None
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDA10BH02
- Darooyab (Iran)Vildagliptin
- eMC (UK label)UK Galvus SmPC
🇮🇷 Registered in Iran Darooyab · G-3925/Vildagliptin
Dosage forms with Iranian generic codes, per Darooyab.
- 14688 · INOSINE ACEDOBEN 500MG TAB · قرص اینوسین آسدوبن ۵۰۰ میلیگرم
- 52522 · VILDAGLIPTIN TABLET ORAL 50 mg · قرص ویلداگلیپتین ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)❌ Not present
- UK SmPC (eMC / MHRA)✅ PresentUK Galvus SmPC · 4.2UK Galvus SmPC · 4.3UK Galvus SmPC · 4.4UK Galvus SmPC · 4.6
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3925/Vildagliptin
- Clinical review⚠ Unverified